Therefore, in this study, we have used RNA ISH to investigate the stromal expression of GREM1 in various skin tumors, and compared the expression of GREM1 between benign and malignant tumors, and between the distinct BCC subtypes. Here, GREM1 is linked to skin basal cell carcinoma.